Merit Historical Cash Flow

MMSI Stock  USD 103.66  0.34  0.33%   
Analysis of Merit Medical cash flow over time is an excellent tool to project Merit Medical Systems future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 106.4 M or Other Non Cash Items of 11.3 M as it is a great indicator of Merit Medical ability to facilitate future growth, repay debt on time or pay out dividends.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Merit Medical Systems latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Merit Medical Systems is a good buy for the upcoming year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

About Merit Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Merit balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Merit's non-liquid assets can be easily converted into cash.

Merit Medical Cash Flow Chart

As of now, Merit Medical's Depreciation is increasing as compared to previous years. The Merit Medical's current Other Non Cash Items is estimated to increase to about 11.3 M, while Sale Purchase Of Stock is forecasted to increase to (4.9 M).

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Total Cashflows From Investing Activities

The net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period.
Most accounts from Merit Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Merit Medical Systems current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
As of now, Merit Medical's Depreciation is increasing as compared to previous years. The Merit Medical's current Other Non Cash Items is estimated to increase to about 11.3 M, while Sale Purchase Of Stock is forecasted to increase to (4.9 M).

Merit Medical cash flow statement Correlations

-0.03-0.14-0.120.01-0.12-0.07-0.14-0.04-0.11-0.14-0.17-0.32-0.04-0.13-0.3-0.130.650.20.190.22
-0.03-0.35-0.180.9-0.56-0.370.1-0.04-0.76-0.4-0.47-0.410.530.760.44-0.020.30.070.570.3
-0.14-0.350.58-0.580.470.460.08-0.280.790.990.690.390.0-0.04-0.64-0.17-0.28-0.34-0.62-0.41
-0.12-0.180.58-0.260.720.80.47-0.390.570.630.890.090.480.17-0.36-0.54-0.58-0.11-0.78-0.77
0.010.9-0.58-0.26-0.67-0.51-0.12-0.03-0.8-0.62-0.6-0.310.40.660.660.020.350.150.680.45
-0.12-0.560.470.72-0.670.940.710.090.580.570.910.10.22-0.26-0.49-0.29-0.69-0.05-0.84-0.93
-0.07-0.370.460.8-0.510.940.750.120.490.560.890.010.45-0.16-0.51-0.3-0.690.06-0.74-0.9
-0.140.10.080.47-0.120.710.750.3-0.050.170.57-0.250.630.21-0.17-0.27-0.52-0.03-0.45-0.82
-0.04-0.04-0.28-0.39-0.030.090.120.3-0.23-0.25-0.160.170.14-0.290.150.48-0.020.190.280.02
-0.11-0.760.790.57-0.80.580.49-0.05-0.230.810.740.57-0.22-0.38-0.54-0.17-0.34-0.3-0.78-0.41
-0.14-0.40.990.63-0.620.570.560.17-0.250.810.760.370.03-0.07-0.66-0.2-0.35-0.32-0.69-0.5
-0.17-0.470.690.89-0.60.910.890.57-0.160.740.760.210.29-0.04-0.52-0.41-0.66-0.2-0.93-0.89
-0.32-0.410.390.09-0.310.10.01-0.250.170.570.370.21-0.14-0.280.260.01-0.07-0.34-0.20.05
-0.040.530.00.480.40.220.450.630.14-0.220.030.29-0.140.490.13-0.2-0.280.11-0.06-0.37
-0.130.76-0.040.170.66-0.26-0.160.21-0.29-0.38-0.07-0.04-0.280.490.24-0.360.12-0.360.04-0.07
-0.30.44-0.64-0.360.66-0.49-0.51-0.170.15-0.54-0.66-0.520.260.130.240.020.150.040.520.4
-0.13-0.02-0.17-0.540.02-0.29-0.3-0.270.48-0.17-0.2-0.410.01-0.2-0.360.020.110.260.420.43
0.650.3-0.28-0.580.35-0.69-0.69-0.52-0.02-0.34-0.35-0.66-0.07-0.280.120.150.11-0.170.550.71
0.20.07-0.34-0.110.15-0.050.06-0.030.19-0.3-0.32-0.2-0.340.11-0.360.040.26-0.170.390.17
0.190.57-0.62-0.780.68-0.84-0.74-0.450.28-0.78-0.69-0.93-0.2-0.060.040.520.420.550.390.84
0.220.3-0.41-0.770.45-0.93-0.9-0.820.02-0.41-0.5-0.890.05-0.37-0.070.40.430.710.170.84
Click cells to compare fundamentals

Merit Medical Account Relationship Matchups

Merit Medical cash flow statement Accounts

201920202021202220232024 (projected)
Sale Purchase Of Stock6.3M(866K)(576K)(2.5M)(5.1M)(4.9M)
Change To Inventory(27.0M)29.4M(25.2M)(47.9M)(32.1M)(30.5M)
Change In Cash(23.0M)12.6M10.8M(7.2M)528.6M555.0M
Free Cash Flow(3.7M)116.0M119.3M69.3M108.5M113.9M
Change In Working Capital(55.7M)34.2M(17.8M)(71.4M)(70.0M)(66.5M)
Begin Period Cash Flow67.4M44.3M56.9M67.8M60.6M63.6M
Other Cashflows From Financing Activities229.4M(14.0M)(11.2M)(35.4M)(75.9M)(72.1M)
Depreciation104.4M106.8M95.8M92.2M101.3M106.4M
Other Non Cash Items26.8M31.0M9.4M15.9M10.8M11.3M
Capital Expenditures81.5M49.3M27.9M45.0M36.7M29.4M
Total Cash From Operating Activities77.8M165.3M147.2M114.3M145.2M152.4M
Net Income5.5M(9.8M)48.5M74.5M94.4M99.1M
Total Cash From Financing Activities33.5M(95.7M)(98.4M)(60.3M)559.3M587.2M
End Period Cash Flow44.3M56.9M67.8M60.6M589.1M618.6M
Stock Based Compensation9.4M14.3M16.1M18.0M21.3M22.4M
Change To Liabilities(2.3M)333K6.1M12.7M14.6M15.3M
Change To Netincome22.8M175.1M20.8M39.8M45.7M30.8M
Other Cashflows From Investing Activities250K(12.9M)(2.1M)(12.4M)(14.2M)(14.9M)
Change To Account Receivables(17.9M)10.4M(8.6M)(15.1M)(9.5M)(10.0M)
Investments(134.5M)250K(37.2M)(57.4M)(184.3M)(175.1M)
Net Borrowings44.5M(88.4M)(108.5M)(44.9M)(40.4M)(38.4M)
Total Cashflows From Investing Activities(134.5M)(58.7M)(37.2M)(57.4M)(66.0M)(69.3M)
Change To Operating Activities(4.9M)(4.8M)(17.8M)(27.1M)(24.4M)(23.1M)
Issuance Of Capital Stock6.3M6.6M21.3M20.1M24.8M39.2M

Currently Active Assets on Macroaxis

When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.091
Earnings Share
2.05
Revenue Per Share
22.847
Quarterly Revenue Growth
0.078
Return On Assets
0.0456
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.